Edition:
United Kingdom

Biomarin Pharmaceutical Q3 GAAP Loss Per Share $0.07


Thursday, 25 Oct 2018 

Oct 25 (Reuters) - Biomarin Pharmaceutical Inc ::BIOMARIN ANNOUNCES THIRD QUARTER 2018 RESULTS.Q3 GAAP LOSS PER SHARE $0.07.Q3 REVENUE $391.7 MILLION VERSUS I/B/E/S VIEW $367.1 MILLION.Q3 EARNINGS PER SHARE VIEW $-0.22 -- THOMSON REUTERS I/B/E/S.BIOMARIN PHARMACEUTICAL - AS OF SEPT 30, 2018, HAD CASH, CASH EQUIVALENTS & INVESTMENTS TOTALING ABOUT $1.6 BILLION, COMPARED TO $1.8 BILLION ON DEC 31, 2017.BIOMARIN PHARMACEUTICAL -SEES FY 2018 TOTAL REVENUES $1,470 MILLION TO $1,530 MILLION.SEES FY 2018 GAAP NET LOSS $115 MILLION TO $165 MILLION.BIOMARIN PHARMACEUTICAL -SEES FY 2018 NON-GAAP INCOME $100 MILLION TO $140 MILLION.